Company Description
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.
The company sells its products through direct sales organizations, such as capital and clinical sales teams.
Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Country | United States |
| Founded | 1995 |
| IPO Date | Jun 13, 2000 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Gary Guthart |
Contact Details
Address: 1020 Kifer Road Sunnyvale, California 94086-5304 United States | |
| Phone | 408 523 2100 |
| Website | intuitive.com |
Stock Details
| Ticker Symbol | ISRG |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001035267 |
| CUSIP Number | 46120E602 |
| ISIN Number | US46120E6023 |
| Employer ID | 77-0416458 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gary S. Guthart Ph.D. | Chief Executive Officer and Director |
| David J. Rosa | President and Director |
| Jamie E. Samath | Executive Vice President, Chief Financial Officer and Head of Business Technology |
| Henry L. Charlton | Executive Vice President and Chief Commercial and Marketing Officer |
| Dr. Brian E. Miller Ph.D. | Executive Vice President and Chief Digital Officer |
| Fredrik Widman | Vice President, Principal Accounting Officer and Corporate Controller |
| Brian King | Vice President, Treasurer and Head of Investor Relations |
| Gary H. Loeb J.D. | Executive Vice President and Chief Legal and Compliance Officer |
| Dr. Christopher R. Carlson Ph.D. | Executive Vice President of Research, Corporate Development and Intuitive Ventures |
| Patricia Wadors | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 14, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 14, 2025 | ARS | Filing |
| Mar 14, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 13, 2025 | 144 | Filing |
| Mar 12, 2025 | 144 | Filing |
| Mar 11, 2025 | 144 | Filing |
| Mar 7, 2025 | 144 | Filing |
| Mar 6, 2025 | 144 | Filing |
| Mar 5, 2025 | 144 | Filing |
| Mar 5, 2025 | 144 | Filing |